Market Overview
Preeclampsia is a pregnancy-related health complication, in which the pregnant woman experiences high blood pressure and signs of damage to another organ system, mostly kidneys, and liver. Generally, preeclampsia begins after 20 weeks of pregnancy in women whose blood pressure had been normal. Some of the most common symptoms of preeclampsia include sudden weight gain, edema, hypertension, and persistent headache.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4606
Market Dynamics
Increasing prevalence of preeclampsia among pregnant women is expected to propel the global preeclampsia diagnostics market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), the prevalence of preeclampsia is around 1 in 25 pregnancies in the U.S. Some women with preeclampsia develop seizures, which is called eclampsia that require immediate medical attention. The most common symptoms of preeclampsia include persistent headache, changes in vision, nausea or vomiting, sudden weight gain, etc.
However, a lack of awareness regarding preeclampsia disease and complications associated with this disease is expected to restrain growth of the global preeclampsia diagnostics market during the forecast period.
Impact of COVID-19
The global preeclampsia diagnostics market witnessed a significant negative impact due to the COVID-19 pandemic. Following the outbreak in China in December 2019, many countries decided to adopt stringent lockdown policies, in order to contain the spread of the virus. These policies led to a massive disruption in various sectors, suspending manufacturing activities temporarily. With the sharp decline in economic activities, the global preeclampsia diagnostics market witnessed a major slump during 2020. However, the market is expected to regain its lost traction with the rollout of vaccines and relaxation in the COVID-19 regulations in the near future.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4606
Key Takeaways
The global preeclampsia diagnostics is expected to witness growth, registering a CAGR of 11.8% over the forecast period. This is owing to increasing product launches by key companies in the market. For instance, in July 2021, LifeCell Diagnostics launched the first comprehensive preeclampsia screening test in India.
Among regions, North America is expected to witness significant growth in the global preeclampsia diagnostics market during the forecast period. This is owing to increasing population and high pregnancy rate in the region.
Asia Pacific is expected to exhibit strong growth, owing to growing awareness regarding the disease among pregnant women.
Key players operating in the global preeclampsia diagnostics market are Roche, DRG INSTRUMENTS GMBH, PerkinElmer Inc., Diabetomics, Inc., Siemens AG, and LionsGate Technologies Inc.,
Detailed Segmentation:
Global Preeclampsia Diagnostics Market, By Test Type:
-
- Blood Tests
- Urine Analysis
- Others
Global Preeclampsia Diagnostics Market, By Product Type:
-
- Instruments
- Consumables
Global Preeclampsia Diagnostics Market, By End User:
-
- Hospital
- Specialty Clinics
- Diagnostic Centers
- Others
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4606
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Preeclampsia Diagnostics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Preeclampsia Diagnostics Industry Impact
Chapter 2 Preeclampsia Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Preeclampsia Diagnostics (Volume and Value) by Type
2.3 Preeclampsia Diagnostics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Preeclampsia Diagnostics Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Preeclampsia Diagnostics Market Analysis
Chapter 6 East Asia Preeclampsia Diagnostics Market Analysis
Chapter 7 Europe Preeclampsia Diagnostics Market Analysis
Chapter 8 South Asia Preeclampsia Diagnostics Market Analysis
Chapter 9 Southeast Asia Preeclampsia Diagnostics Market Analysis
Chapter 10 Middle East Preeclampsia Diagnostics Market Analysis
Chapter 11 Africa Preeclampsia Diagnostics Market Analysis
Chapter 12 Oceania Preeclampsia Diagnostics Market Analysis
Chapter 13 South America Preeclampsia Diagnostics Market Analysis
Chapter 14 Company Profiles and Key Figures in Preeclampsia Diagnostics Business
Chapter 15 Preeclampsia Diagnostics Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
Related Market Intelligence Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com